By Laura Lutz
Des Moines, Oct. 16 - Ivivi Technologies, Inc. arranged a $5 million private placement of shares.
The Pinnacle Fund, LP, has agreed to buy 1,000,000 common shares at $5.00 each.
Proceeds will be used for working capital and general corporate purposes.
Ivivi expects the deal to settle "promptly," according to an 8-K filing with the Securities and Exchange Commission.
Based in Northvale, N.J., Ivivi is a medical technology company focused on an electrotherapeutic technology platform.
| Issuer: | Ivivi Technologies, Inc.
|
| Issue: | Stock
|
| Amount: | $5 million
|
| Shares: | 1,000,000
|
| Price: | $5.00
|
| Warrants: | No
|
| Investor: | The Pinnacle Fund, LP
|
| Pricing date: | Oct. 15
|
| Stock symbol: | Amex: II
|
| Stock price: | $4.7999 at close Oct. 15
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
